Benefits of Streamlined Point-of-Care Trial Designs
Robert M. Califf, Patrizia Cavazzoni, Janet Woodcock
Abstract
This Viewpoint discusses the benefits of streamlined point-of-care trial designs in clinical research, using lessons learned from the UK RECOVERY study of dexamethasone dosing for patients with COVID-19 and hypoxia.
Topics & Concepts
MedicineDosingClinical trialIntensive care medicinePoint of careDexamethasoneHypoxia (environmental)Coronavirus disease 2019 (COVID-19)Clinical study designMedical physicsNursingInternal medicineInfectious disease (medical specialty)DiseaseOxygenOrganic chemistryChemistryMetabolomics and Mass Spectrometry StudiesSepsis Diagnosis and TreatmentAdrenal Hormones and Disorders